Authors:
van Crevel, R
de Lange, WCM
Vanderpuye, NA
van Soolingen, D
Hoogkamp-Korstanje, JAA
van Deuren, M
Kullberg, BJ
van Herwaarden, C
van der Meer, JWM
Citation: R. Van Crevel et al., The impact of nontuberculous mycobacteria on management of presumed pulmonary tuberculosis, INFECTION, 29(2), 2001, pp. 59-63
Authors:
Schouten, MA
Willems, RJL
Kraak, WAG
Top, J
Hoogkamp-Korstanje, JAA
Voss, A
Citation: Ma. Schouten et al., Molecular analysis of Tn1546-like elements in vancomycin-resistant enterococci isolated from patients in Europe shows geographic transposon type clustering, ANTIM AG CH, 45(3), 2001, pp. 986-989
Citation: Mf. Yuan et al., SHV-14, a novel beta-lactamase variant in Klebsiella pneumoniae isolates from Nijmegen, The Netherlands, ANTIM AG CH, 45(1), 2001, pp. 309-311
Citation: Jaa. Hoogkamp-korstanje et J. Roelofs-willemse, Comparative in vitro activity of moxifloxacin against Gram-positive clinical isolates, J ANTIMICRO, 45(1), 2000, pp. 31-39
Authors:
Hoogkamp-Korstanje, JAA
Moesker, H
Bruyn, GAW
Citation: Jaa. Hoogkamp-korstanje et al., Ciprofloxacin upsilon placebo for treatment of Yersinia enterocolitica triggered reactive arthritis, ANN RHEUM D, 59(11), 2000, pp. 914-917
Authors:
Stobberingh, EE
Arends, J
Hoogkamp-Korstanje, JAA
Goessens, WHF
Visser, MR
Buiting, AGM
Debets-Ossenkopp, YJ
van Ketel, RJ
van Ogtrop, ML
Sabbe, LJM
Voorn, GP
Winter, HLJ
van Zeijl, JH
Citation: Ee. Stobberingh et al., Occurrence of extended-spectrum beta-lactamases (ESBL) in Dutch hospitals, INFECTION, 27(6), 1999, pp. 348-354
Authors:
Schouten, MA
Voss, A
Hoogkamp-Korstanje, JAA
Citation: Ma. Schouten et al., Antimicrobial susceptibility patterns of enterococci causing infections inEurope, ANTIM AG CH, 43(10), 1999, pp. 2542-2546